Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The role of "test and treat" has its limits
| The first 150 words of the full text of this article appear below. |
This article originally appeared in BMJ USA
Dyspepsia is defined as pain or discomfort centered in the upper abdomen, and it is estimated that 2-6% of patients presenting to family physicians have dyspepsia as their presenting complaint. 1 2 Two articles in this issue (BMJ USA p 319 and p 324) provide further proof that non-invasive testing for Helicobacter pylori, followed by treatment (the "test and treat" strategy) of those who test positive, is effective in alleviating symptoms, reducing the need for endoscopic investigations, and decreasing the overall cost of managing this common condition.
Until recently, the diagnostic test for H pylori
recommended for use in primary care was serology. This low-cost test is
widely available and is inexpensive, allowing primary care physicians to perform H pylori testing in their offices. As the
prevalence of H pylori has fallen in developed countries,
the predictive value of the serologic test for H pylori has
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+